Market Tracker

08/28 6:01pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.15
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
1.75
-17.27%
Year-to-Date

Today’s Trading

Previous close1.15
Today’s open1.15
Day’s range1.14 - 1.17
Volume738,114
Average volume (3 months)1,140,001
Market cap$231.3M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
CORICorium International...-0.27-2.52%
DRNADicerna Pharmaceutic...+0.89+8.69%
ASMBAssembly Biosciences...+0.36+2.78%
NVLSNivalis Therapeutics...-0.24-1.55%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateSeptember 7, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts